Budesonide is recommended as one of the first-line drugs for treatment of eosinophilic esophagitis (EoE), a chronic immune-mediated inflammatory disease, and in a recent study researchers updated a ...
March 17, 2009 — Budesonide nasal wash may be clinically effective in decreasing symptoms of chronic rhinosinusitis without suppression of the hypothalamic-pituitary-adrenal axis, according to the ...
The Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for PCR tests, monoclonal antibodies, and vaccines. It is time to add a new weapon in this war and grant a similar ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
If budesonide-formoterol were to become available over the counter (OTC) and used as-needed for mild asthma, it would save lives and cut healthcare costs, according to a computer modeling study ...
San Antonio, Tex., - March 19, 2005 – New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to ...
Please provide your email address to receive an email when new articles are posted on . The complete response letter (CRL) denied approval for budesonide oral suspension (BOS) and recommended ...
Budesonide, a glucocorticoid, was proven to be a highly effective agent in preventing the development of lung tumors in A/J mice. In a lung tumor bioassay, budesonide produced 70% inhibition of tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback